Table Graph
      published meta-analysis   sensitivity analysis   studies

Aspirin in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsRECOVERY (Aspirin), 2022 0.96 [0.89; 1.04] 0.96[0.89; 1.04]RECOVERY (Aspirin), 202210%14,892NAnot evaluable deathsdetailed resultsRECOVERY (Aspirin), 2022 0.96 [0.89; 1.04] 0.96[0.89; 1.04]RECOVERY (Aspirin), 202210%14,892NAnot evaluable deaths (time to event analysis only)detailed resultsRECOVERY (Aspirin), 2022 0.96 [0.89; 1.04] 0.96[0.89; 1.04]RECOVERY (Aspirin), 202210%14,892NAnot evaluable hospital dischargedetailed resultsRECOVERY (Aspirin), 2022 1.06 [1.02; 1.10] 1.06[1.02; 1.10]RECOVERY (Aspirin), 202210%14,892NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-04-24 18:47 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 1257 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons